Tuesday, October 13, 2026

UK's 15-18MW Aikido Offshore Wind Project Targets 2028 Launch as Europe Races to 50GW

Britain plans a 15-18MW floating offshore wind project called Aikido for December 2028, part of its 50GW offshore wind goal by 2030. The UK ranks third globally in offshore wind capacity behind China and Germany, with 14GW operational in 2025. Floating turbine technology unlocks 80% of previously inaccessible deepwater sites across European seas.

Source Trace Score1 source document1 with a live linkVerifiability: Basic
UK's 15-18MW Aikido Offshore Wind Project Targets 2028 Launch as Europe Races to 50GW
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

A 15-18 megawatt floating offshore wind project named Aikido will launch off Britain's coast by December 2028, advancing the UK's 50-gigawatt offshore wind target under its Net Zero Strategy.

Britain generated 14 gigawatts of offshore wind in 2025—enough for 12 million homes—ranking third globally behind China and Germany. The UK invested £20 billion in offshore projects between 2020-2025, creating 30,000 jobs across coastal regions.

Floating turbines deploy in waters too deep for fixed-bottom installations, opening 80% of offshore wind resources previously inaccessible. Norway's 88MW Hywind Scotland project, operational since 2017, proved commercial viability despite 30-40% higher costs than fixed structures.

Aikido would power 15,000 homes annually. Modern offshore turbines generate three to four times more electricity than 2015 models through larger rotor diameters and improved efficiency.

Europe installed 17 gigawatts of offshore wind in 2025, with £65 billion projected investment through 2030. Britain, Netherlands, and Germany control 70% of regional capacity as energy markets shift from fossil fuels—EU gas imports dropped 40% since 2021.

The UK auctions seabed rights through Crown Estate tenders, generating £9 billion in recent rounds. BP and Shell now hold 25% of British offshore wind capacity as oil majors pivot to renewables.

Grid infrastructure lags demand. National Grid plans £54 billion in transmission upgrades by 2030 to connect offshore sites with population centers. Connection delays currently average four to six years.

Aikido's timeline depends on regulatory approvals requiring 18-24 months for environmental impact assessments and maritime navigation clearances.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleIEEE Spectrum
    This Offshore Wind Turbine Will House a Data Center Underwater

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com